<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83567">
  <stage>Registered</stage>
  <submitdate>4/02/2009</submitdate>
  <approvaldate>25/05/2009</approvaldate>
  <actrnumber>ACTRN12609000340235</actrnumber>
  <trial_identification>
    <studytitle>The effects of coronary sinus based left atrial pacing on systemic hemodynamics in cardiac resynchronization therapy patients</studytitle>
    <scientifictitle>Acute evaluation of effects of coronary sinus based left atrial pacing on systemic hemodynamics in cardiac resynchronization therapy patients</scientifictitle>
    <utrn />
    <trialacronym>CSLA</trialacronym>
    <secondaryid>CSLA</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Patients requiring Cardiac Resynchronization Therapy</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Left atrial pacing using a left atrial lead and electrophyisiology heart catheter stimulation for 30 seconds. This will be compared to the hemodynamic effects of traditional right atrial (RA)pacing using the implanted RA lead. Several pacing interventions (using a combination of right atrial and left atrial pacing combinations) and will be performed using a dedicated 4-channel pacing system. For each pacing intervention, the optimal timing setting will be determined as calculated by a real-time cardiac hemodynamic monitoring system.  Each pacing intervention will be evaluated based on the resulting hemodynamic response. The entire pacing intervention will take 30 minutes and is administered only once in an acute setting.</interventions>
    <comparator>none</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Hemodynamic measurements (changes in cardiac output) with coronary sinus (CS) based single and multisite left atrial (LA) pacing configurations</outcome>
      <timepoint>hemodynamic changes will be evaluated 30 seconds after pacing stimulation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>systemic hemodynamics (cardiac output) of cardiac resynchronization therapy (CRT) employing bi-atrial pacing including both coronary sinus based left atrial pacing combined with right atrial based pacing</outcome>
      <timepoint>hemodynamic changes will be evaluated 30 seconds after pacing stimulation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>undergoing cardiac resynchronization therapy (CRT) implantation
able to consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>no persistant or permanent atrial fibrillation (AF)
no recent myocardial infarction (MI) or Cardiac surgery</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures>Control is right atrial pacing measurement for each patient. Pacing configuration order of testing will be randomized.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/03/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>ON</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>St Jude Medical</primarysponsorname>
    <primarysponsoraddress>2100 Derry Rd, Suite 400, Mississauga, ON, L5N 0B3</primarysponsoraddress>
    <primarysponsorcountry>Canada</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>St Jude Medical</fundingname>
      <fundingaddress>2100 Derry Rd, Suite 400, Mississauga, ON, L5N 0B3</fundingaddress>
      <fundingcountry>Canada</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>St Jude Medical</fundingname>
      <fundingaddress>2100 Derry Rd, Suite 400, Mississauga, ON, L5N 0B3</fundingaddress>
      <fundingcountry>Canada</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to evaluate the effects of left atrial pacing on the overall hemodynamic response in patients receive cardiac resynchronization therapy.  It is believed that left atrial pacing may improve hemodynamics.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Southlake Regional Health Center Research Ethics Board (REB)</ethicname>
      <ethicaddress />
      <ethicapprovaldate>15/12/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Canada</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mike Benser</name>
      <address>15900 Valley View Court, Sylmar, CA, 91342-3577</address>
      <phone>+1 818-493-2345</phone>
      <fax />
      <email>MBenser@sjm.com</email>
      <country>United States of America</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Linnea Aasen-Johnston</name>
      <address>2100 Derry Rd, Suite 400, Mississauga, ON, L5N 0B3</address>
      <phone>+1 905-286-4009</phone>
      <fax />
      <email>LAasen-Johnston@sjm.com</email>
      <country>Canada</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Linnea Aasen-Johnston</name>
      <address>2100 Derry Rd, Suite 400, Mississauga, ON, L5N 0B3</address>
      <phone>+1 905-286-4009</phone>
      <fax />
      <email>LAasen-Johnston@sjm.com</email>
      <country>Canada</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>